MedPath

MEXBRAIN

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Glucarpidase Improves Kidney Recovery in Methotrexate-Associated Acute Kidney Injury

• A recent study found that glucarpidase treatment significantly improves kidney recovery in patients with methotrexate-associated acute kidney injury (AKI). • Patients receiving glucarpidase showed a 2.7-fold higher odds of kidney recovery compared to those without glucarpidase, according to the study. • Glucarpidase treatment was also associated with faster time-to-kidney recovery and reduced risks of neutropenia and transaminitis. • The findings support the use of glucarpidase to improve renal and extrarenal outcomes in adults experiencing MTX-AKI.
© Copyright 2025. All Rights Reserved by MedPath